News
U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that ...
Merck is particularly exposed to the tariff threat, as much of its production of Keytruda takes place at facilities in ...
Here’s what to know. In February, Merck officials presented to Delaware’s Council of Development Finance to make their ...
Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...
Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.
The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster ...
The S&P 500, the Dow Jones, and the NASDAQ all moved between 0.8% and 1% lower by mid-afternoon. Palantir (PLTR) stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback